In this Season 3 premiere of The Business of AI in Healthcare, Dr. Robert Kaiser sits down with Henry O’Connell, CEO and Founder of Canary Speech, to explore one of the most talked-about frontiers in healthcare AI: voice biomarkers.

Together, they unpack how speech and language analytics can unlock medically meaningful signals, what it takes to move voice-based AI from research to real-world clinical workflows, and why this category is becoming increasingly relevant across neurology, behavioral health, and cognitive health.

If you’re a healthcare leader, innovator, investor, or technologist tracking AI diagnostics, clinical decision support, and the future of digital health, this conversation ...